Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Omega Fund Management LTD — CANCERVAX CORP insider: 2 transactions · InsiderLens

Home / Insiders / Omega Fund Management LTD

Omega Fund Management LTD

10% owner at CANCERVAX CORP · on record since May 9, 2006
10% owner at PROFILE TECHNOLOGIES INC · on record since Nov 10, 2014

Insider trading activity of Omega Fund Management LTD

Transactions on record: 2; since Aug 6, 2009

Open-market buys: 0

Open-market sells: 2; $242.4K

Companies traded: 1; last filing Aug 6, 2009

Figures computed from official regulatory filings — methodology.

Companies where Omega Fund Management LTD has traded

CANCERVAX CORP2 tx · $242.4K · Aug 6, 2009

Track record of Omega Fund Management LTD

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Omega Fund Management LTD

Co-insiders of Omega Fund Management LTD

Omega Fund III GP, L.P.CANCERVAX CORP +1
Omega Fund III G.P., Ltd.CANCERVAX CORP +1
Omega Fund III, L.P.CANCERVAX CORP +1
Sigma Holding LTDCANCERVAX CORP +1
Stampacchia OtelloCANCERVAX CORP +1
3i GROUP PLCCANCERVAX CORP
ADVENT MANAGEMENT III L PCANCERVAX CORP

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

ADVENT PRIVATE EQUITY FUND III AFFILIATESCANCERVAX CORP

ADVENT PRIVATE EQUITY FUND III A LTD PARTNERSHIPCANCERVAX CORP

ADVENT PRIVATE EQUITY FUND III B LTD PARTNERSHIPCANCERVAX CORP

ADVENT PRIVATE EQUITY FUND III C LTD PARTNERSHIPCANCERVAX CORP

ADVENT PRIVATE EQUITY FUND III D LTD PARTNERSHIPCANCERVAX CORP

ADVENT PRIVATE EQUITY FUND III GMBH & CO KGCANCERVAX CORP

Agunzo JohnPROFILE TECHNOLOGIES INC

AKER HAZEL MCANCERVAX CORP

Alder MatthiasCANCERVAX CORP

Alvarez-Masterton Sharon RoseCANCERVAX CORP

AMGEN INCCANCERVAX CORP

Armstrong Acquisition Corp.CANCERVAX CORP

ARNOLD DEBRA JCANCERVAX CORP

Baeuerle PatrickCANCERVAX CORP

Balencic Jordan PaulCANCERVAX CORP

Baylor-Henry MinniePROFILE TECHNOLOGIES INC

BENJAMIN JERRYCANCERVAX CORP

Berriman John ECANCERVAX CORP

BIGHAM MICHAELPROFILE TECHNOLOGIES INC

Boxmeyer Kathryn M.PROFILE TECHNOLOGIES INC

Bradway Robert ACANCERVAX CORP

Brenner Randall B.PROFILE TECHNOLOGIES INC

Brodmerkel ThomasCANCERVAX CORP

CARTER MICHAEL GCANCERVAX CORP

CHRISTENSON CHARLESPROFILE TECHNOLOGIES INC

Danish BioVenture General Partner ApSPROFILE TECHNOLOGIES INC

Dhingra KapilCANCERVAX CORP

Diamond Lawrence M.CANCERVAX CORP

Dietz Thomas JohnPROFILE TECHNOLOGIES INC

DONDERO JAMES DPROFILE TECHNOLOGIES INC

EVANS MURPHYPROFILE TECHNOLOGIES INC

Evans Thomas K. W.PROFILE TECHNOLOGIES INC

Fagerberg JanCANCERVAX CORP

Franson Timothy RPROFILE TECHNOLOGIES INC

Gallagher Carol GiltnerCANCERVAX CORP

GAMMON GUYCANCERVAX CORP

GARNER CAM LCANCERVAX CORP

Geib Robert C.PROFILE TECHNOLOGIES INC

GEMINO HENRY EDMUNDPROFILE TECHNOLOGIES INC

GRAU ULRICH MCANCERVAX CORP

Guille AndrewCANCERVAX CORP

HALE DAVID FCANCERVAX CORP

Harper Sean ECANCERVAX CORP

Company	Filed	Type	Qty	Price	Value · USD	Src
CANCERVAX CORP	Aug 6, 2009	Sell	-18,000	6.06	$109.1K	SEC
CANCERVAX CORP	Aug 6, 2009	Sell	-22,000	6.06	$133.3K	SEC